Market Place
Sourcing Support
Aspiro Pharma`s Generics Chlorpromazine HCl Receives Approval in US
18 Nov 2024 //
FDA
Samsung Bioepis`s Biologic Epysqli Receives Suppl Approval in US
15 Nov 2024 //
FDA
Eisai`s Biologic Leqembi Receives Suppl Approval in US
14 Nov 2024 //
FDA
Celltrion`s Biologic Herzuma Receives Suppl Approval in US
14 Nov 2024 //
FDA
Mylan Gmbh`s Biologic Ogivri Receives Suppl Approval in US
13 Nov 2024 //
FDA
Cosette Pharma`s Generics Sucralfate Receives Approval in US
13 Nov 2024 //
FDA
Macleods`s Generics Fenofibrate Receives Approval in US
12 Nov 2024 //
FDA
Teva Pharma`s Generics Fedratinib Receives Tentative Approval in US
07 Nov 2024 //
FDA
Apotex`s Generics Rivaroxaban HCl Receives Approval in US
07 Nov 2024 //
FDA
Aspiro Pharma`s Generics Thiamine HCl Receives Approval in US
06 Nov 2024 //
FDA
Micro Labs`s Generics Metolazone Receives Approval in US
06 Nov 2024 //
FDA
IdentiRx`s Generics Ciprofloxacin HCl Receives Approval in US
05 Nov 2024 //
FDA
Upsher Smith`s Generics Deflazacort Receives Approval in US
05 Nov 2024 //
FDA
Xiamen`s Generics Topiramate Receives Approval in US
05 Nov 2024 //
FDA
Torrent`s Generics Deferasirox Receives Approval in US
05 Nov 2024 //
FDA
Dr. Reddys`s Generics Dasatinib Receives Tentative Approval in US
04 Nov 2024 //
FDA
Macleods`s Generics Lansoprazole Receives Approval in US
04 Nov 2024 //
FDA
AstraZeneca`s Byetta Receives Approval in US
01 Nov 2024 //
FDA
Somerst`s Generics Dicyclomine HCl Receives Approval in US
01 Nov 2024 //
FDA
Sanofi`s Biologic Soliqua Receives Suppl Approval in US
01 Nov 2024 //
FDA
Cipla`s Generics Sodium Thiosulfate Receives Tentative Approval in US
01 Nov 2024 //
FDA
Sanofi`s Biologic Sarclisa Receives Suppl Approval in US
25 Oct 2024 //
FDA
Sandoz`s Biologic Wyost (Denosumab-bbdz) Receives Suppl Approval in US
24 Oct 2024 //
FDA
Sandoz`s Biologic Jubbonti (Denosumab-bbdz) Receives Suppl Approval in US
24 Oct 2024 //
FDA
Regeneron`s Biologic Inmazeb Receives Suppl Approval in US
24 Oct 2024 //
FDA
Novitium Pharma`s Generics Estradiol Receives Approval in US
23 Oct 2024 //
FDA
Osmotica Pharma`s Generics Carbamazepine Receives Approval in US
22 Oct 2024 //
FDA
Hetero Labs`s Generics Mycophenolate Mofetil Receives Approval in US
22 Oct 2024 //
FDA
Sandoz`s Biologic Zarxio (Filgrastim) Receives Suppl. Approval in US
22 Oct 2024 //
FDA
Lexenpharm`s Generics Formoterol Fumarate Receives Approval in US
22 Oct 2024 //
FDA
Prinston`s Generics Brexpiprazole Receives Tentative Approval in US
21 Oct 2024 //
FDA
Mankind Pharma`s Generics Levalbuterol HCl Receives Approval in US
21 Oct 2024 //
FDA
Astellas`s Biologic Vyloy (Zolbetuximab) Receives Approval in US
18 Oct 2024 //
FDA
Alvotech`s Biologic Selarsi (Ustekinumab) Receives Approval in US
18 Oct 2024 //
FDA
Allergan`s Biologic Botox Cosmetic Receives Suppl. Approval in US
18 Oct 2024 //
FDA
Prinston`s Generics Empagliflozin Receives Tentative Approval in US
15 Oct 2024 //
FDA
Prinston`s Generics Metformin HCl Receives Tentative Approval in US
15 Oct 2024 //
FDA
Dexcel`s Generics Tafamidis Receives Tentative Approval in US
15 Oct 2024 //
FDA
Somerset`s Generics Ephedrine Sulfate Receives Tentative Approval in US
15 Oct 2024 //
FDA
Apopharma`s Generics Rivaroxaban Receives Tentative Approval in US
15 Oct 2024 //
FDA
Hetero`s Generics Azacitidine Receives Approval in US
15 Oct 2024 //
FDA
Pfizer`s Biologic Hympavzi (Marstacimab-hncq) Receives Approval in US
11 Oct 2024 //
FDA
UCB`s Biologic Bimzelx (Bimekizumab) Receives Suppl. Approval in US
11 Oct 2024 //
FDA
EMD`s Biologic Bavencio (Avelumab) Receives Suppl Approval in US
11 Oct 2024 //
FDA
Macleods Pharma`s Generics Rivaroxaban Receives Tentative Approval in US
11 Oct 2024 //
FDA
Auxilium`s Biologic Xiaflex (Clostridium) Receives Suppl. Approval in US
11 Oct 2024 //
FDA
Hikma`s Generics Ephedrine Sulfate Receives Approval in US
11 Oct 2024 //
FDA
Macleods`s Generics Amlodipine, Valsartan Receives Approval in US
11 Oct 2024 //
FDA
Accord`s Biologic Imuldosa (Ustekinumab) Receives Suppl Approval in US
10 Oct 2024 //
FDA
Regeneron Pharma`s Biologic Eylea Receives Suppl Approval in US
10 Oct 2024 //
FDA
Genentech`s Itovebi (Inavolisib) Receives Approval in US
10 Oct 2024 //
FDA
Regeneron`s Biologic Eylea HD (Aflibercept) Receives Suppl Approval in US
10 Oct 2024 //
FDA
Senores`s Generics Topiramate Receives Approval in US
10 Oct 2024 //
FDA
Somerset`s Generics Timolol Receives Approval in US
10 Oct 2024 //
FDA
Macleods`s Generics Linezolid Receives Approval in US
10 Oct 2024 //
FDA
Somerset`s Generics Lacosamide Receives Approval in US
09 Oct 2024 //
FDA
Zydus Pharma`s Generics Paliperidone Receives Approval in US
08 Oct 2024 //
FDA
Saptalis`s Generics Glycopyrrolate Receives Approval in US
07 Oct 2024 //
FDA
Novartis`s Biologic Cosentyx (Secukinumab) Receives Approval in US
04 Oct 2024 //
FDA
Bristol Myers`s Biologic Opdivo (Nivolumab) Receives Suppl Approval in US
03 Oct 2024 //
FDA
